25 XP   0   0   10

Clene Inc.
Buy, Hold or Sell?

Let's analyse Clene together

PenkeI guess you are interested in Clene Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Clene Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Clene Inc.

I send you an email if I find something interesting about Clene Inc..

Quick analysis of Clene (30 sec.)










What can you expect buying and holding a share of Clene? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
6.3%

What is your share worth?

Current worth
$0.10
Expected worth in 1 year
$0.18
How sure are you?
43.8%

+ What do you gain per year?

Total Gains per Share
$0.08
Return On Investment
23.9%

For what price can you sell your share?

Current Price per Share
$0.34
Expected price per share
$0.25 - $0.38
How sure are you?
50%

1. Valuation of Clene (5 min.)




Live pricePrice per Share (EOD)

$0.34

Intrinsic Value Per Share

$-2.64 - $-3.06

Total Value Per Share

$-2.54 - $-2.96

2. Growth of Clene (5 min.)




Is Clene growing?

Current yearPrevious yearGrowGrow %
How rich?$13.3m-$1.1m$14.8m108.5%

How much money is Clene making?

Current yearPrevious yearGrowGrow %
Making money-$12.9m-$3.4m-$9.4m-73.5%
Net Profit Margin-7,634.1%-9,772.8%--

How much money comes from the company's main activities?

3. Financial Health of Clene (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#636 / 1010

Most Revenue
#607 / 1010

Most Profit
#604 / 1010

Most Efficient
#929 / 1010

What can you expect buying and holding a share of Clene? (5 min.)

Welcome investor! Clene's management wants to use your money to grow the business. In return you get a share of Clene.

What can you expect buying and holding a share of Clene?

First you should know what it really means to hold a share of Clene. And how you can make/lose money.

Speculation

The Price per Share of Clene is $0.337. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Clene.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Clene, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.10. Based on the TTM, the Book Value Change Per Share is $0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Clene.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.08-23.5%-0.10-28.6%-0.06-17.3%-0.05-15.5%-0.05-15.5%
Usd Book Value Change Per Share-0.06-18.5%0.025.9%-0.02-5.4%0.011.9%0.011.9%
Usd Dividend Per Share0.000.0%0.000.1%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.06-18.5%0.026.0%-0.02-5.4%0.012.0%0.012.0%
Usd Price Per Share0.30-0.70-2.57-5.69-5.69-
Price to Earnings Ratio-0.95--2.95--16.49-6.11-6.11-
Price-to-Total Gains Ratio-4.81-212.47--51.03-378.61-378.61-
Price to Book Ratio2.88--19.52--80.72-235.56-235.56-
Price-to-Total Gains Ratio-4.81-212.47--51.03-378.61-378.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.337
Number of shares2967
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.020.01
Usd Total Gains Per Share0.020.01
Gains per Quarter (2967 shares)59.7919.62
Gains per Year (2967 shares)239.1878.49
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1523522917768
294694682155146
3147047073232224
4189389465309302
523117311856387380
628140714247464458
732164216638541536
837187619029619614
9422111214110696692
10462346238012773770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%3.013.00.018.8%3.013.00.018.8%3.013.00.018.8%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%6.07.03.037.5%6.07.03.037.5%6.07.03.037.5%
Dividend per Share1.00.03.025.0%1.00.011.08.3%1.00.015.06.3%1.00.015.06.3%1.00.015.06.3%
Total Gains per Share2.02.00.050.0%6.06.00.050.0%7.06.03.043.8%7.06.03.043.8%7.06.03.043.8%

Fundamentals of Clene

About Clene Inc.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company also develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.

Fundamental data was last updated by Penke on 2024-04-11 04:21:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Clene Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Clene earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Clene to the Biotechnology industry mean.
  • A Net Profit Margin of -5,984.1% means that $-59.84 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Clene Inc.:

  • The MRQ is -5,984.1%. The company is making a huge loss. -2
  • The TTM is -7,634.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-5,984.1%TTM-7,634.1%+1,649.9%
TTM-7,634.1%YOY-9,772.8%+2,138.8%
TTM-7,634.1%5Y-8,720.8%+1,086.7%
5Y-8,720.8%10Y-8,720.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,984.1%-200.1%-5,784.0%
TTM-7,634.1%-216.8%-7,417.3%
YOY-9,772.8%-288.3%-9,484.5%
5Y-8,720.8%-449.1%-8,271.7%
10Y-8,720.8%-605.5%-8,115.3%
1.1.2. Return on Assets

Shows how efficient Clene is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Clene to the Biotechnology industry mean.
  • -19.4% Return on Assets means that Clene generated $-0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Clene Inc.:

  • The MRQ is -19.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.4%TTM-23.8%+4.4%
TTM-23.8%YOY-8.0%-15.8%
TTM-23.8%5Y-9.5%-14.3%
5Y-9.5%10Y-9.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.4%-13.3%-6.1%
TTM-23.8%-12.8%-11.0%
YOY-8.0%-11.7%+3.7%
5Y-9.5%-13.9%+4.4%
10Y-9.5%-15.7%+6.2%
1.1.3. Return on Equity

Shows how efficient Clene is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Clene to the Biotechnology industry mean.
  • -76.0% Return on Equity means Clene generated $-0.76 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Clene Inc.:

  • The MRQ is -76.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -51.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-76.0%TTM-51.0%-25.0%
TTM-51.0%YOY-108.0%+57.0%
TTM-51.0%5Y8.5%-59.5%
5Y8.5%10Y8.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-76.0%-16.9%-59.1%
TTM-51.0%-16.1%-34.9%
YOY-108.0%-15.1%-92.9%
5Y8.5%-19.3%+27.8%
10Y8.5%-20.2%+28.7%

1.2. Operating Efficiency of Clene Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Clene is operating .

  • Measures how much profit Clene makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Clene to the Biotechnology industry mean.
  • An Operating Margin of -5,841.2% means the company generated $-58.41  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Clene Inc.:

  • The MRQ is -5,841.2%. The company is operating very inefficient. -2
  • The TTM is -8,434.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-5,841.2%TTM-8,434.1%+2,592.9%
TTM-8,434.1%YOY-22,112.9%+13,678.8%
TTM-8,434.1%5Y-15,665.3%+7,231.2%
5Y-15,665.3%10Y-15,665.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,841.2%-296.2%-5,545.0%
TTM-8,434.1%-232.5%-8,201.6%
YOY-22,112.9%-298.2%-21,814.7%
5Y-15,665.3%-492.1%-15,173.2%
10Y-15,665.3%-632.4%-15,032.9%
1.2.2. Operating Ratio

Measures how efficient Clene is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 59.41 means that the operating costs are $59.41 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Clene Inc.:

  • The MRQ is 59.412. The company is inefficient in keeping operating costs low. -1
  • The TTM is 70.289. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ59.412TTM70.289-10.878
TTM70.289YOY222.129-151.840
TTM70.2895Y131.208-60.918
5Y131.20810Y131.2080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ59.4123.231+56.181
TTM70.2893.310+66.979
YOY222.1293.890+218.239
5Y131.2085.739+125.469
10Y131.2087.876+123.332

1.3. Liquidity of Clene Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Clene is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.53 means the company has $1.53 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Clene Inc.:

  • The MRQ is 1.534. The company is able to pay all its short-term debts. +1
  • The TTM is 3.838. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.534TTM3.838-2.304
TTM3.838YOY4.373-0.534
TTM3.8385Y6.104-2.266
5Y6.10410Y6.1040.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5343.890-2.356
TTM3.8384.173-0.335
YOY4.3735.344-0.971
5Y6.1046.126-0.022
10Y6.1046.448-0.344
1.3.2. Quick Ratio

Measures if Clene is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Clene to the Biotechnology industry mean.
  • A Quick Ratio of 1.68 means the company can pay off $1.68 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Clene Inc.:

  • The MRQ is 1.679. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.638. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.679TTM3.638-1.960
TTM3.638YOY6.045-2.406
TTM3.6385Y5.749-2.111
5Y5.74910Y5.7490.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6793.514-1.835
TTM3.6383.998-0.360
YOY6.0455.380+0.665
5Y5.7496.105-0.356
10Y5.7496.404-0.655

1.4. Solvency of Clene Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Clene assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Clene to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.74 means that Clene assets are financed with 74.4% credit (debt) and the remaining percentage (100% - 74.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Clene Inc.:

  • The MRQ is 0.744. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.778. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.744TTM0.778-0.034
TTM0.778YOY1.040-0.262
TTM0.7785Y0.810-0.032
5Y0.81010Y0.8100.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7440.339+0.405
TTM0.7780.336+0.442
YOY1.0400.271+0.769
5Y0.8100.366+0.444
10Y0.8100.389+0.421
1.4.2. Debt to Equity Ratio

Measures if Clene is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Clene to the Biotechnology industry mean.
  • A Debt to Equity ratio of 290.9% means that company has $2.91 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Clene Inc.:

  • The MRQ is 2.909. The company is unable to pay all its debts with equity. -1
  • The TTM is 1.721. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.909TTM1.721+1.188
TTM1.721YOY9.550-7.829
TTM1.7215Y16.254-14.533
5Y16.25410Y16.2540.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9090.388+2.521
TTM1.7210.402+1.319
YOY9.5500.335+9.215
5Y16.2540.426+15.828
10Y16.2540.461+15.793

2. Market Valuation of Clene Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Clene generates.

  • Above 15 is considered overpriced but always compare Clene to the Biotechnology industry mean.
  • A PE ratio of -0.95 means the investor is paying $-0.95 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Clene Inc.:

  • The EOD is -1.064. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.947. Based on the earnings, the company is expensive. -2
  • The TTM is -2.948. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.064MRQ-0.947-0.117
MRQ-0.947TTM-2.948+2.001
TTM-2.948YOY-16.493+13.545
TTM-2.9485Y6.107-9.055
5Y6.10710Y6.1070.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.064-2.264+1.200
MRQ-0.947-2.629+1.682
TTM-2.948-2.680-0.268
YOY-16.493-4.145-12.348
5Y6.107-6.257+12.364
10Y6.107-6.254+12.361
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Clene Inc.:

  • The EOD is -1.491. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.327. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.888. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.491MRQ-1.327-0.164
MRQ-1.327TTM-2.888+1.561
TTM-2.888YOY-7.231+4.343
TTM-2.8885Y-32.676+29.788
5Y-32.67610Y-32.6760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.491-2.973+1.482
MRQ-1.327-3.333+2.006
TTM-2.888-3.553+0.665
YOY-7.231-5.605-1.626
5Y-32.676-8.376-24.300
10Y-32.676-8.865-23.811
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Clene is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.88 means the investor is paying $2.88 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Clene Inc.:

  • The EOD is 3.232. Based on the equity, the company is fair priced.
  • The MRQ is 2.877. Based on the equity, the company is underpriced. +1
  • The TTM is -19.518. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD3.232MRQ2.877+0.355
MRQ2.877TTM-19.518+22.396
TTM-19.518YOY-80.723+61.205
TTM-19.5185Y235.565-255.083
5Y235.56510Y235.5650.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.2321.896+1.336
MRQ2.8772.115+0.762
TTM-19.5182.093-21.611
YOY-80.7232.884-83.607
5Y235.5653.542+232.023
10Y235.5653.916+231.649
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Clene Inc..

3.1. Insider Transactions

Insiders are holding 40.131% of the shares of Clene Inc..

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-10David J MatlinBUY2500020.41
2023-06-26John Henry StevensBUY3164550.8
2023-06-26Robert Dee EtheringtonBUY250000.81
2023-06-16David J MatlinBUY15000000.8

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Clene Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0620.020-416%-0.018-71%0.007-1058%0.007-1058%
Book Value Per Share--0.1040.106-2%-0.009+109%0.003+3099%0.003+3099%
Current Ratio--1.5343.838-60%4.373-65%6.104-75%6.104-75%
Debt To Asset Ratio--0.7440.778-4%1.040-28%0.810-8%0.810-8%
Debt To Equity Ratio--2.9091.721+69%9.550-70%16.254-82%16.254-82%
Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Eps---0.079-0.096+22%-0.058-26%-0.052-34%-0.052-34%
Free Cash Flow Per Share---0.057-0.059+5%-0.086+52%-0.063+12%-0.063+12%
Free Cash Flow To Equity Per Share---0.0560.023-348%-0.052-7%0.013-543%0.013-543%
Gross Profit Margin--1.0041.001+0%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max---3.060--------
Intrinsic Value_10Y_min---2.645--------
Intrinsic Value_1Y_max---0.290--------
Intrinsic Value_1Y_min---0.285--------
Intrinsic Value_3Y_max---0.885--------
Intrinsic Value_3Y_min---0.845--------
Intrinsic Value_5Y_max---1.495--------
Intrinsic Value_5Y_min---1.386--------
Market Cap43280910.000+11%38529000.00090222075.000-57%329422950.000-88%730285087.500-95%730285087.500-95%
Net Profit Margin---59.841-76.341+28%-97.728+63%-87.208+46%-87.208+46%
Operating Margin---58.412-84.341+44%-221.129+279%-156.653+168%-156.653+168%
Operating Ratio--59.41270.289-15%222.129-73%131.208-55%131.208-55%
Pb Ratio3.232+11%2.877-19.518+778%-80.723+2905%235.565-99%235.565-99%
Pe Ratio-1.064-12%-0.947-2.948+211%-16.493+1642%6.107-116%6.107-116%
Price Per Share0.337+11%0.3000.703-57%2.565-88%5.686-95%5.686-95%
Price To Free Cash Flow Ratio-1.491-12%-1.327-2.888+118%-7.231+445%-32.676+2362%-32.676+2362%
Price To Total Gains Ratio-5.399-12%-4.807212.474-102%-51.028+962%378.613-101%378.613-101%
Quick Ratio--1.6793.638-54%6.045-72%5.749-71%5.749-71%
Return On Assets---0.194-0.238+23%-0.080-59%-0.095-51%-0.095-51%
Return On Equity---0.760-0.510-33%-1.080+42%0.085-992%0.085-992%
Total Gains Per Share---0.0620.020-410%-0.018-71%0.007-1044%0.007-1044%
Usd Book Value--13390000.00013675500.000-2%-1157000.000+109%418562.500+3099%418562.500+3099%
Usd Book Value Change Per Share---0.0620.020-416%-0.018-71%0.007-1058%0.007-1058%
Usd Book Value Per Share--0.1040.106-2%-0.009+109%0.003+3099%0.003+3099%
Usd Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Usd Eps---0.079-0.096+22%-0.058-26%-0.052-34%-0.052-34%
Usd Free Cash Flow---7258167.000-7636041.750+5%-11047500.000+52%-8125385.438+12%-8125385.438+12%
Usd Free Cash Flow Per Share---0.057-0.059+5%-0.086+52%-0.063+12%-0.063+12%
Usd Free Cash Flow To Equity Per Share---0.0560.023-348%-0.052-7%0.013-543%0.013-543%
Usd Market Cap43280910.000+11%38529000.00090222075.000-57%329422950.000-88%730285087.500-95%730285087.500-95%
Usd Price Per Share0.337+11%0.3000.703-57%2.565-88%5.686-95%5.686-95%
Usd Profit---10173000.000-12902000.000+27%-3424250.000-66%-5895125.000-42%-5895125.000-42%
Usd Revenue--170000.000163500.000+4%118250.000+44%128500.000+32%128500.000+32%
Usd Total Gains Per Share---0.0620.020-410%-0.018-71%0.007-1044%0.007-1044%
 EOD+5 -3MRQTTM+14 -22YOY+16 -185Y+16 -2010Y+16 -20

4.2. Fundamental Score

Let's check the fundamental score of Clene Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.064
Price to Book Ratio (EOD)Between0-13.232
Net Profit Margin (MRQ)Greater than0-59.841
Operating Margin (MRQ)Greater than0-58.412
Quick Ratio (MRQ)Greater than11.679
Current Ratio (MRQ)Greater than11.534
Debt to Asset Ratio (MRQ)Less than10.744
Debt to Equity Ratio (MRQ)Less than12.909
Return on Equity (MRQ)Greater than0.15-0.760
Return on Assets (MRQ)Greater than0.05-0.194
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Clene Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.126
Ma 20Greater thanMa 500.375
Ma 50Greater thanMa 1000.406
Ma 100Greater thanMa 2000.412
OpenGreater thanClose0.338
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  227-125102101203-10796-386-290



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets52,341
Total Liabilities38,951
Total Stockholder Equity13,390
 As reported
Total Liabilities 38,951
Total Stockholder Equity+ 13,390
Total Assets = 52,341

Assets

Total Assets52,341
Total Current Assets38,852
Long-term Assets13,489
Total Current Assets
Cash And Cash Equivalents 28,821
Short-term Investments 6,179
Net Receivables 1,338
Inventory 37
Other Current Assets 2,477
Total Current Assets  (as reported)38,852
Total Current Assets  (calculated)38,852
+/-0
Long-term Assets
Property Plant Equipment 13,431
Long-term Assets Other 58
Long-term Assets  (as reported)13,489
Long-term Assets  (calculated)13,489
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities25,330
Long-term Liabilities13,621
Total Stockholder Equity13,390
Total Current Liabilities
Short-term Debt 20,106
Short Long Term Debt 19,503
Accounts payable 1,504
Other Current Liabilities 3,720
Total Current Liabilities  (as reported)25,330
Total Current Liabilities  (calculated)44,833
+/- 19,503
Long-term Liabilities
Long term Debt 7,152
Capital Lease Obligations 5,506
Long-term Liabilities Other 85
Long-term Liabilities  (as reported)13,621
Long-term Liabilities  (calculated)12,743
+/- 878
Total Stockholder Equity
Common Stock13
Retained Earnings -242,723
Accumulated Other Comprehensive Income 199
Other Stockholders Equity 255,901
Total Stockholder Equity (as reported)13,390
Total Stockholder Equity (calculated)13,390
+/-0
Other
Capital Stock13
Cash and Short Term Investments 35,000
Common Stock Shares Outstanding 128,423
Current Deferred Revenue0
Liabilities and Stockholders Equity 52,341
Net Debt 3,340
Net Invested Capital 40,045
Net Working Capital 13,522
Property Plant and Equipment Gross 20,318
Short Long Term Debt Total 32,161



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
68,243
58,531
73,284
73,037
63,063
53,361
44,542
36,004
44,493
39,888
67,845
60,433
52,341
52,34160,43367,84539,88844,49336,00444,54253,36163,06373,03773,28458,53168,243000
   > Total Current Assets 
7,610
7,610
39,635
62,989
53,343
68,158
65,393
54,583
42,449
31,587
21,486
29,195
24,822
53,371
46,446
38,852
38,85246,44653,37124,82229,19521,48631,58742,44954,58365,39368,15853,34362,98939,6357,6107,610
       Cash And Cash Equivalents 
0
0
0
59,275
48,041
63,007
60,552
50,288
12,930
7,253
7,267
18,332
18,442
49,243
42,113
28,821
28,82142,11349,24318,44218,3327,2677,25312,93050,28860,55263,00748,04159,275000
       Short-term Investments 
0
0
0
0
0
0
0
0
23,586
19,033
8,966
4,983
0
0
0
6,179
6,1790004,9838,96619,03323,58600000000
       Net Receivables 
0
0
1,300
2,169
123
2,802
1,280
1,613
1,917
2,149
1,724
2,966
3,114
1,019
1,148
1,338
1,3381,1481,0193,1142,9661,7242,1491,9171,6131,2802,8021232,1691,30000
       Inventory 
31
31
32
191
355
53
41
41
38
107
38
43
88
52
104
37
371045288433810738414153355191323131
   > Long-term Assets 
0
0
0
5,254
5,188
5,126
7,644
8,480
10,912
12,955
14,518
15,298
15,066
14,474
13,987
13,489
13,48913,98714,47415,06615,29814,51812,95510,9128,4807,6445,1265,1885,254000
       Property Plant Equipment 
5,571
5,571
5,408
5,254
5,188
5,126
7,586
8,422
10,854
12,897
14,460
15,240
15,008
14,416
13,929
13,431
13,43113,92914,41615,00815,24014,46012,89710,8548,4227,5865,1265,1885,2545,4085,5715,571
       Other Assets 
0
0
2,321
1,029
0
0
58
58
58
58
58
58
0
0
0
0
0000585858585858001,0292,32100
> Total Liabilities 
0
0
0
67,902
94,607
99,209
67,351
50,466
51,344
45,105
45,323
41,256
41,515
46,312
39,027
38,951
38,95139,02746,31241,51541,25645,32345,10551,34450,46667,35199,20994,60767,902000
   > Total Current Liabilities 
8,597
8,597
5,730
11,668
4,086
4,519
4,831
6,026
5,466
7,655
6,154
13,857
16,876
5,735
15,268
25,330
25,33015,2685,73516,87613,8576,1547,6555,4666,0264,8314,5194,08611,6685,7308,5978,597
       Short-term Debt 
0
0
0
384
341
369
415
493
612
563
564
6,980
10,335
591
10,185
20,106
20,10610,18559110,3356,980564563612493415369341384000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
6,418
9,751
0
9,588
19,503
19,5039,58809,7516,41800000000000
       Accounts payable 
1,933
1,933
645
1,124
739
1,143
1,023
1,923
3,313
4,526
3,454
3,014
608
846
1,889
1,504
1,5041,8898466083,0143,4544,5263,3131,9231,0231,1437391,1246451,9331,933
       Other Current Liabilities 
758
758
2,487
10,048
2,894
2,895
3,281
3,610
1,541
2,566
2,136
3,863
5,933
4,298
3,194
3,720
3,7203,1944,2985,9333,8632,1362,5661,5413,6103,2812,8952,89410,0482,487758758
   > Long-term Liabilities 
0
0
0
56,234
90,521
94,690
62,520
44,440
45,878
37,450
39,169
27,399
24,639
40,577
23,759
13,621
13,62123,75940,57724,63927,39939,16937,45045,87844,44062,52094,69090,52156,234000
       Long term Debt Total 
0
0
0
1,949
1,844
10,378
19,172
14,484
14,712
15,551
15,726
0
0
16,017
0
0
0016,0170015,72615,55114,71214,48419,17210,3781,8441,949000
       Other Liabilities 
0
0
0
52,295
86,744
78,122
39,155
20,891
20,673
11,277
12,924
2,555
0
0
0
0
00002,55512,92411,27720,67320,89139,15578,12286,74452,295000
       Deferred Long Term Liability 
0
0
2,321
260
214
69,163
34,049
18,100
18,157
9,847
11,438
0
0
8,201
0
0
008,2010011,4389,84718,15718,10034,04969,1632142602,32100
> Total Stockholder Equity
0
0
0
341
-36,076
-25,925
5,686
12,597
2,017
-563
-9,319
3,237
-1,627
21,533
21,406
13,390
13,39021,40621,533-1,6273,237-9,319-5632,01712,5975,686-25,925-36,076341000
   Common Stock
12
12
12
6
6
6
6
6
6
6
6
7
8
13
13
13
1313138766666666121212
   Retained Earnings Total Equity00-230,132-204,989-193,219-192,165-181,189-176,655-163,301-167,724-196,668-193,317-153,561000
   Accumulated Other Comprehensive Income 
0
0
0
325
349
288
201
233
233
86
80
203
221
174
89
199
199891742212038086233233201288349325000
   Capital Surplus 
0
0
0
153,571
156,886
170,449
173,203
175,659
178,433
180,534
182,760
196,246
203,133
251,478
0
0
00251,478203,133196,246182,760180,534178,433175,659173,203170,449156,886153,571000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
57
57
59
153,571
156,886
170,449
173,203
175,659
178,433
180,534
182,760
196,246
203,133
243,277
251,994
255,901
255,901251,994243,277203,133196,246182,760180,534178,433175,659173,203170,449156,886153,571595757



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue654
Cost of Revenue-1,826
Gross Profit-1,172-1,172
 
Operating Income (+$)
Gross Profit-1,172
Operating Expense-39,368
Operating Income-40,540-40,540
 
Operating Expense (+$)
Research Development25,217
Selling General Administrative13,101
Selling And Marketing Expenses1,050
Operating Expense39,36839,368
 
Net Interest Income (+$)
Interest Income1,389
Interest Expense-4,558
Other Finance Cost-1,387
Net Interest Income-4,556
 
Pretax Income (+$)
Operating Income-40,540
Net Interest Income-4,556
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-49,504-31,576
EBIT - interestExpense = -45,098
-49,504
-44,946
Interest Expense4,558
Earnings Before Interest and Taxes (EBIT)-40,540-44,946
Earnings Before Interest and Taxes (EBITDA)-38,835
 
After tax Income (+$)
Income Before Tax-49,504
Tax Provision-0
Net Income From Continuing Ops-40,385-49,504
Net Income-49,504
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses41,194
Total Other Income/Expenses Net-8,9644,556
 

Technical Analysis of Clene
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Clene. The general trend of Clene is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Clene's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Clene Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.36 < 0.365 < 0.38.

The bearish price targets are: 0.304 > 0.25.

Tweet this
Clene Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Clene Inc.. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Clene Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Clene Inc.. The current macd is -0.02346722.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Clene price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Clene. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Clene price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Clene Inc. Daily Moving Average Convergence/Divergence (MACD) ChartClene Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Clene Inc.. The current adx is 13.96.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Clene shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Clene Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Clene Inc.. The current sar is 0.38257806.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Clene Inc. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Clene Inc.. The current rsi is 39.13. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Clene Inc. Daily Relative Strength Index (RSI) ChartClene Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Clene Inc.. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Clene price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Clene Inc. Daily Stochastic Oscillator ChartClene Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Clene Inc.. The current cci is -79.50724364.

Clene Inc. Daily Commodity Channel Index (CCI) ChartClene Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Clene Inc.. The current cmo is -22.70434786.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Clene Inc. Daily Chande Momentum Oscillator (CMO) ChartClene Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Clene Inc.. The current willr is -73.6.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Clene is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Clene Inc. Daily Williams %R ChartClene Inc. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Clene Inc..

Clene Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Clene Inc.. The current atr is 0.03471275.

Clene Inc. Daily Average True Range (ATR) ChartClene Inc. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Clene Inc.. The current obv is 74,666,763.

Clene Inc. Daily On-Balance Volume (OBV) ChartClene Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Clene Inc.. The current mfi is 43.84.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Clene Inc. Daily Money Flow Index (MFI) ChartClene Inc. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Clene Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Clene Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Clene Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.126
Ma 20Greater thanMa 500.375
Ma 50Greater thanMa 1000.406
Ma 100Greater thanMa 2000.412
OpenGreater thanClose0.338
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Clene with someone you think should read this too:
  • Are you bullish or bearish on Clene? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Clene? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Clene Inc.

I send you an email if I find something interesting about Clene Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Clene Inc..

Receive notifications about Clene Inc. in your mailbox!